SEC Form 4 · accession 0001638599-17-000117
Fortress Biotech, Inc. · FBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael S Weiss
Officer — Exec. VC - Strategic Dev. · Director · 10% Owner
Period of report
Jan 1, 2017
Accepted (ET)
Jan 27, 2017 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001429260
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001F1 | Jan 1, 2017 | A | 552,698 | $0.00 | A | 8,001,170 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase Common StockF2 | $2.10 | holding | — | — | — | — | Dec 19, 2023 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1Represents an award of restricted shares of the Issuer's common stock made pursuant to the Fortress Biotech, Inc. Long Term Incentive Plan.
- F2One-third of the shares vested on each of December 19, 2014, 2015 and 2016.